Astria Therapeutics (ATXS) P/E (2015 - 2026)
Astria Therapeutics (ATXS) P/E from Jun 30, 2015 to Jan 23, 2026. The TTM Astria Therapeutics (ATXS) P/E is -5.72. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Astria Therapeutics (ATXS)
| Year | P/E | Change |
|---|---|---|
| 2026 | -5.72 | -3.90% |
| 2025 | -5.96 | +12.72% |
| 2024 | -5.28 | +35.04% |
| 2023 | -3.91 | -2.98% |
| 2022 | -4.03 | +586.83% |
| 2021 | -0.59 | -91.95% |
| 2020 | -7.30 | -92.01% |
| 2019 | -91.36 | +985.89% |
| 2018 | -8.41 | -16.60% |
| 2017 | -10.09 | -35.57% |
| 2016 | -15.66 | -77.24% |
| 2015 | -68.78 | N/A |
Comparison Astria Therapeutics (ATXS) P/E with competitors
Astria Therapeutics (ATXS) P/E is -5.72.